Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Amortization of Deferred Charges (2018 - 2022)

Corbus Pharmaceuticals Holdings has reported Amortization of Deferred Charges over the past 5 years, most recently at $172734.0 for Q1 2022.

  • For Q1 2022, Amortization of Deferred Charges rose 13.37% year-over-year to $172734.0; the TTM value through Mar 2022 reached $659789.0, up 12.92%, while the annual FY2021 figure was $639415.0, 12.09% up from the prior year.
  • Amortization of Deferred Charges for Q1 2022 was $172734.0 at Corbus Pharmaceuticals Holdings, up from $167461.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $333865.0 in Q1 2018 and troughed at $89179.0 in Q1 2019.
  • A 5-year average of $157634.1 and a median of $145734.0 in 2019 define the central range for Amortization of Deferred Charges.
  • Biggest five-year swings in Amortization of Deferred Charges: crashed 73.29% in 2019 and later skyrocketed 55.32% in 2020.
  • Year by year, Amortization of Deferred Charges stood at $333865.0 in 2018, then plummeted by 60.53% to $131791.0 in 2019, then grew by 12.09% to $147723.0 in 2020, then grew by 13.36% to $167461.0 in 2021, then grew by 3.15% to $172734.0 in 2022.
  • Business Quant data shows Amortization of Deferred Charges for CRBP at $172734.0 in Q1 2022, $167461.0 in Q4 2021, and $162318.0 in Q3 2021.